Is There any Difference between Modern Valves and Self and Balloon Expandable Valves?

At present TAVR is a valid alternative to treat different risk groups of patients with severe aortic stenosis.  Among the different valves, there are two types, the self-expanding (SEV) and the balloon expandable (BEV) valves, that are the most implanted and the most researched by randomized studies across different risk groups. There are different generations<a href="https://solaci.org/en/2022/12/16/is-there-any-difference-between-modern-valves-and-self-and-balloon-expandable-valves/" title="Read more" >...</a>

Válvula Tricúspide: nuevas opciones de tratamiento estructural percutáneo

Watch Again Tricuspid Valve: New Options for Structural Percutaneous Treatment

Enjoy once again a new SOLACI Sessions event: “Tricuspid Valve: New Options for Structural Percutaneous Treatment” on our YouTube channel. The event, sponsored by P&F, was attended by renowned opinion leaders in the region and featured important dissertations and case study discussions. Watch it here below! Tricuspid Valve: New Options for Structural Percutaneous Treatment

Valve-in-Valve Shows Good Evolution after 2 Years

The degeneration of bioprostheses in aortic position occurs at approximately after 10 to 15 years. In this scenario, the treatment of choice used to be redo surgery, but with the evolution of transcatheter aortic valve replacement (TAVR), it became a valid alternative with a level IIa B evidence. While there are currently multiple analyses of<a href="https://solaci.org/en/2022/12/02/valve-in-valve-shows-good-evolution-after-2-years/" title="Read more" >...</a>

Miami Valves 2023 - Descuento SOLACI 30%

Miami Valves 2023: 30% Off for SOLACI Members

On February 2-4, 2023, Miami Valves 2023 will be held in Miami, Florida, USA. This is an international event featuring expert guests from around the world, with a highly educational scientific program on transcatheter therapies and valvular and structural heart disease. SOLACI provides institutional support to the Congress and, as such, we are offering an<a href="https://solaci.org/en/2022/11/28/miami-valves-2023-30-off-for-solaci-members/" title="Read more" >...</a>

¿Qué usar para medir funcionalmente una lesión coronaria en el contexto de estenosis aórtica severa?

Edge-to-Edge Repair Reduces Hospitalization and Mortality Rates in Secondary Mitral Valve Regurgitation?

Severe secondary mitral valve regurgitation is associated to hospitalization and mortality.  The COAPT study has shown the superiority of guideline directed medical therapy at maximal tolerated doses according to guidelines (GDMT) plus edge-to-edge transcatheter repair (TEER) versus GMDT alone. However, at present there is no information on the impact of hospitalizations and their relationship to<a href="https://solaci.org/en/2022/11/22/edge-to-edge-repair-reduces-hospitalization-and-mortality-rates-in-secondary-mitral-valve-regurgitation/" title="Read more" >...</a>

SOLACI-SOCIME 2022 - Live Case Pulmonary Valve

LIVE CASE “Pulmonar Valve” from Hospital Universitario Austral, BA, Argentina – SOLACI-SOCIME 2022

✔️ LIVE CASE “Pulmonar Valve” from “Hospital Universitario Austral, BA, Argentina – SOLACI-SOCIME 2022. Structural Room. ✔️ SOLACI-SOCIME 2022 Scientific Session.

Pulmonary Valve – SOLACI-SOCIME 2022

✔️ Pulmonary Valve – SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Scientific Sessions 👨‍🏫 Contents: 00:10 – How to select the type of THV in pulmonary valve – Dr. Juan Pablo Sandoval (MEX).

SOLACI-SOCIME 2022 – MITRAL VALVE Session

✔️ MITRAL VALVE Session ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:07 – Welcoming Words- Dr. Guering Eid Lidt (MEX) 01:26 – Mitral valve replacement – Dr. Ignacio Amat (ESP) 18:15 – Transcatheter treatment of mitral valve regurgitation – Dr. Luis Nombela Franco (ESP) 34:57 – Mitral valve-in-valve – Dr. Guering Eid Lidt (MEX)

SOLACI-SOCIME 2022 – LIVE CASE 2 | Pulmonary Valve Implantation with a Melody Prosthesis

✔️ Live Case 2, Main Arena – SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Video

Apixaban and Valve Thrombosis after TAVR

TAVR has been associated with early valve thrombosis, characterized by thrombus formation in the prosthetic valve with or without valve dysfunction. This dysfunction is related to leaflet thickening and reduced motion, reduced effective orifice area, or increased transvalvular gradient. A multidetector CT scan allows the dynamic assessment of valves and ruling out fibrosis vs. thrombosis. <a href="https://solaci.org/en/2022/09/14/apixaban-and-valve-thrombosis-after-tavr/" title="Read more" >...</a>